$215 million lands on menopause. Under 1% of aging research has ever studied it.

On June 4, 2026, Melinda French Gates announced $215 million in new funding for women's health through her organization Pivotal, bringing her total commitment in this area to more than $600 million over two years [s2]. Coverage described it, accurately, as the largest sustained private bet on women's health — and specifically on midlife and menopause — that anyone has placed [s3].

The number is worth setting against a different one.

The gap the money is aimed at

In December 2023, Nature Aging published an analysis of how the biology of aging is actually studied. Its finding: while "over 70% of the most prevalent age-related diseases are associated with and/or potentially impacted by menopause," the authors found that "preclinical studies including a menopausal phenotype make up < 1% of published aging biology research" [s4]. In absolute terms, fewer than 1% — 17,678 — of the preclinical studies relating to those diseases considered menopause at all [s4].

The mechanism behind that gap is mundane and structural. The standard laboratory models of aging — fruit flies, roundworms, rodents — do not undergo menopause in the way humans do, and the paper argues they consequently fail to recapitulate female aging trajectories [s4]. Aging research has not ignored women so much as it has built its instruments around an organism that does not have the transition, and then aged that organism.

This is a single bibliometric analysis, and its estimate depends on how "menopausal phenotype" was operationalized in a literature search. But the direction is not seriously contested, and the figure has become the field's shorthand for the problem.

Where the money is actually going

Two grants were named on announcement day, totaling $50 million of the $215 million.

The Menopause Society received $10 million to train healthcare professionals in women's midlife health and expand outreach where menopause care is least available [s1]. The society describes the target as "MenoDeserts" — geographies where specialized menopause care is limited or absent — and frames the grant under an initiative spanning clinical education, digital innovation, and research translation [s1]. "Menopause is a universal life stage, but quality care is not universally available," said Dr. Stephanie Faubion, the society's medical director [s1].

Co-Impact received $40 million for work embedding mental health support into maternal and primary care, with particular emphasis on Africa [s2].

TIME reported that Pivotal is also making a joint grant with Wellcome Leap for research on heart disease in women [s3]. Pivotal has said further partners will be announced later in the year [s3].

The distribution matters for reading the announcement honestly. Of what has been named so far, the largest tranche goes to maternal mental health in low-income settings — important work, but not menopause. The menopause-specific grant is $10 million, and it funds clinician education and outreach rather than research. That is a defensible allocation: the Nature Aging gap is a research gap, but the delivery gap is real too, and training clinicians produces effects on a much shorter timescale than funding preclinical models does. It is simply not the same problem.

The context nobody announced

French Gates framed the commitment partly as a signal to other funders. Fortune reported that other philanthropists have become reluctant to fund women's health work under the current administration, and that funding from other sources has stalled [s5]. "I'm trying to send a signal," she said, that women's health remains viable to support [s5].

"A woman can't step into her power if we neglect her health," she said [s3]. On the historical shape of the problem: "We funded things around the human body as if the man's body was the default body" [s3].

That framing is doing real work. Private philanthropy at this scale is not a substitute for federal research funding — $215 million is a rounding error against the National Institutes of Health budget — but it is fast, it is directable, and it does not require an appropriation. What it cannot do is change the incentive structure that produced a sub-1% figure in the first place, which runs through study sections, animal model availability, and what gets funded as mechanistically interesting.

What this does and does not resolve

It resolves some of the clinician-training deficit, which is the piece a patient encounters first. The Menopause Society notes that healthcare professionals receive only limited training in women's midlife health [s1] — a gap that produces the familiar experience of a patient describing symptoms to a clinician who has had no formal instruction in them.

It does not resolve the underlying evidence problem. Training clinicians distributes existing knowledge more widely; it does not generate new knowledge about what menopause does to cardiovascular, skeletal, and neurological aging. That requires models, cohorts, and years.

What to watch

The remaining $165 million. Pivotal has signaled further partners in 2026 and beyond [s3], and whether any meaningful share goes to preclinical or mechanistic research — as opposed to education, delivery, and advocacy — is the test of whether this money touches the gap the field keeps citing. Also worth watching: whether the Wellcome Leap cardiovascular collaboration [s3] produces a funded program with published protocols, and whether federal funding for menopause research moves in either direction.

Sources

• [s1] The Menopause Society Receives Grant to Expand Education and Outreach Where Access to Care Is Most Limited, The Menopause Society, 2026-06-04.
• [s2] Melinda French Gates donates $215 million to improve women's health worldwide, ABC7 Chicago / Associated Press, 2026-06-04.
• [s3] Melinda French Gates Is Donating $215 Million to Women's Health, TIME, 2026-06-04.
• [s4] Gilmer, Hettinger, Tuakli-Wosornu et al., Female aging: when translational models don't translate, Nature Aging 3(12):1500–1508, 2023-12-05.
• [s5] Melinda French Gates announces $215 million for women's health and urges philanthropists to act without fear, Fortune, 2026-06-04.